These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3104067)

  • 1. Vasoconstrictor expression of human platelet-vessel wall interactions: inhibition by the Ca2+ entry blocker flunarizine.
    Van Nueten JM; De Ridder W; Van Gorp L; De Clerck F
    Eur J Pharmacol; 1987 Jan; 133(3):301-8. PubMed ID: 3104067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blocker.
    De Clerck F; Van Nueten JM
    Biochem Pharmacol; 1983 Mar; 32(5):765-71. PubMed ID: 6404280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin.
    De Clerck F; Van Nueten JM
    Thromb Res; 1982 Sep; 27(6):713-27. PubMed ID: 6817452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
    Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
    Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
    Rybicki JP; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin.
    Alonso MT; Sanchez A; Garcia-Sancho J
    Biochem J; 1990 Dec; 272(2):435-43. PubMed ID: 2125206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modification of platelet-induced coronary vasoconstriction by a thromboxane receptor antagonist.
    Verheggen R; Schrör K
    J Cardiovasc Pharmacol; 1986; 8(3):483-90. PubMed ID: 2425162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.